MAP4K4 and metabolic dysfunction-associated steatotic liver disease: In this study, we provide the first evidence to demonstrate that MAP4K4 mRNA expression in human liver biopsies is positively correlated with NAFLD severity and that silencing of MAP4K4 in vitro protects human hepatocytes against lipotoxic damage.